Anzeige
❌
Mehr »
Dienstag, 20.10.2026 - Börsentäglich über 12.000 News
Lithium vor 2022. Kernkraft vor dem Comeback. Tiefseebergbau jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoCompass puts treatment-resistant depression on the map with first awareness day
MiUltragenyx makes swift $413M return on FDA review vouchers after summer of gene therapy nods
MiConnected Evidence: From Insight to Impac
MiBuilding trust in AI-assisted SLR: A reinvention of systematic literature reviews
MiGalderma bulks up dermatology portfolio with $1.5B acquisition of Zo Skin Health
MiUnited lands 'clearcut win' as Liquidia agrees to $380M settlement in Tyvaso patent infringement saga
MiAbbVie marks calendar for 'Time For Treks' in National Parks Foundation, CLL Society partnership
MiFTC seeks sanctions against Martin Shkreli over alleged pharma ban violations
MiNantWorks' Soon-Shiong puts chips behind manufacturing disruptors in new rounds for Prolific Machines, Multiply Labs
MiSanofi dodges EU fine over alleged disparagement of CSL flu vaccine
13.10.Beyond Competitive Intelligence: Predicting Commercial Success Earlier in Drug Development
13.10.J&J's new pharma chief expects Icotyde's psoriasis launch momentum to repeat across indications
13.10.Syndax shares fall 17% after calling it quits on Niktimvo fibrosis program
13.10.BARDA awards Kaléo $96M contract to deploy auto-injector for chemical threat preparedness
13.10.ARPA-H program manager talks 'first-shoring' philosophy behind $125M RNA manufacturing network challenge
13.10.UCB fashions 'Wear It Out' project with empowering t-shirts, community for inflammatory disease patients
13.10.Galderma sculpts new narrative around menopausal skin changes to fill awareness gap
12.10.Data Precision Is Healthcare Marketing's Growth Engine
12.10.Mirum on its way to 3rd rare liver indication for Livmarli
12.10.Why Timing Has Become HCP Marketing's Biggest Challenge
12.10.Bausch + Lomb names Appio interim CEO as Saunders hits the exit again
12.10.Invenra deals patient perspectives into the ADC game with custom card deck
12.10.Asahi Kasei buyout yields novel FDA herpes nod in immunocompromised patients
12.10.Media OS is designed to tackle healthcare advertising's identity challenge
12.10.Why Patient Voice Must Shape Pharma Strategy